These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5115212)

  • 1. Central nervous system agents. 3. Structure-activity relationship of a series of diphenylaminopropanols.
    Keasling HH; Moffett RB
    J Med Chem; 1971 Nov; 14(11):1106-11. PubMed ID: 5115212
    [No Abstract]   [Full Text] [Related]  

  • 2. Agents acting on the central nervous system. 14. 1-(p-Alkanoylphenoxy)-3-(N 4 -arylpiperazinyl)propan-2-ols. A new class of antidepressants.
    Rastogi SN; Anand N; Prasad CR
    J Med Chem; 1972 Mar; 15(3):286-91. PubMed ID: 5059212
    [No Abstract]   [Full Text] [Related]  

  • 3. A study of structure-activity relationships of a series of diphenylaminopropanols by factor analysis.
    Weiner ML; Weiner PH
    J Med Chem; 1973 Jun; 16(6):655-61. PubMed ID: 4714997
    [No Abstract]   [Full Text] [Related]  

  • 4. -adrenergic blocking agents. 3-(3-Substituted-amino-2-hydroxypropoxy)-4-substituted-1,2,5-thiadiazoles.
    Wasson BK; Gibson WK; Stuart RS; Williams HW; Yates CH
    J Med Chem; 1972 Jun; 15(6):651-5. PubMed ID: 4402289
    [No Abstract]   [Full Text] [Related]  

  • 5. Central nervous system agents. 1. Synthesis of diphenyl-tert-aminopropanols.
    Moffett RB; Strube RE; Skaletzky L
    J Med Chem; 1971 Nov; 14(11):1088-100. PubMed ID: 5115210
    [No Abstract]   [Full Text] [Related]  

  • 6. Some cyclic derivatives of 2-cyclohexylamino-1-phenylethanol.
    Irwin WJ; Wheeler DL; Harper NJ
    J Med Chem; 1972 Apr; 15(4):445-6. PubMed ID: 5019578
    [No Abstract]   [Full Text] [Related]  

  • 7. Selective inhibition of 2 -adrenergic receptors by 1-(2,4-dimethylanilino)-3-isopropylamino-2-propanol.
    Sinha JN; Rastogi VK; Parmar SS
    Eur J Pharmacol; 1972 Aug; 19(2):285-7. PubMed ID: 5071799
    [No Abstract]   [Full Text] [Related]  

  • 8. Synergism by atropine of central stimulant properties of phenylpropanolamine.
    Davis WM; Pinkerton JT
    Toxicol Appl Pharmacol; 1972 May; 22(1):138-45. PubMed ID: 5034981
    [No Abstract]   [Full Text] [Related]  

  • 9. Central nervous system agents. 2. Synthesis of diphenyl primary and secondary aminopropanols.
    Moffett RB; Pickering TL
    J Med Chem; 1971 Nov; 14(11):1100-6. PubMed ID: 5115211
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacological study of a new adrenergic beta receptor blocking agent: 1-isopropylamino-3-(1,2,3,4-tetrahydro-1,4-ethano-5-naphthoxy)-2-propanol hydrochloride (K4423)].
    Bergamaschi M; Mandelli V; Tommasini R; Turba C; Usardi MM
    Boll Chim Farm; 1972 Nov; 111(11):667-87. PubMed ID: 4144099
    [No Abstract]   [Full Text] [Related]  

  • 11. Central nervous system agents. 4. Analogs of 3-amino-2-phenylpropiophenone.
    Moffett RB; Hester JB
    J Med Chem; 1972 Dec; 15(12):1243-7. PubMed ID: 4635967
    [No Abstract]   [Full Text] [Related]  

  • 12. [Circulatory effects of a new specific beta adrenergic blocking agent, (o-(2-hydroxy-3-(tert. butylamino)-propoxyl)-benzonitrile, Kö 1366)].
    Gilfrich HJ; Rahn KH; Nicolescu RF
    Arzneimittelforschung; 1973 Jun; 23(6):768-71. PubMed ID: 4146902
    [No Abstract]   [Full Text] [Related]  

  • 13. New benzothiazines. 4. 1H-2,3-benzothiazin-4(3H)-one 2,2-dioxide and 2H-1,2-benzothiazin-3(4H)-one 1,1-dioxide nitrogen derivatives with central nervous system activity.
    Sianesi E; Redaelli R; Magistretti MJ; Massarani E
    J Med Chem; 1973 Oct; 16(10):1133-7. PubMed ID: 4749470
    [No Abstract]   [Full Text] [Related]  

  • 14. Toxicity of diethanolamine in mice.
    Blum K; Huizenga CG; Ryback RS; Johnson DK; Geller I
    Toxicol Appl Pharmacol; 1972 Jun; 22(2):175-85. PubMed ID: 5048047
    [No Abstract]   [Full Text] [Related]  

  • 15. Compounds affecting the central nervous system. 3. Substituted 1,1-diaryl-t-aminopropanols and related compounds.
    Barron DI; Hall GH; Natoff IL; Ridley HF; Spickett RG; Vallance DK
    J Med Chem; 1965 Nov; 8(6):836-41. PubMed ID: 4380069
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacologic evaluation of 3-butoxy-l-phenoxy-propanol-(2), a new substance with choleretic activity].
    Hofrichter G; Hampel H; Liehn HD; Ludwig E
    Arzneimittelforschung; 1974 Jan; 24(1):111-8. PubMed ID: 4406096
    [No Abstract]   [Full Text] [Related]  

  • 17. Resolution of optical isomers of 5-allyl-5-(beta-hydroxypropyl)-barbituric acid (Ipronal, Axeen) and their pharmacological activity.
    Bobranski B; Wilimowski M; Barczynska J; Seniuta R; Sedzimirska B; Witkowska M
    Arch Immunol Ther Exp (Warsz); 1973; 21(2):299-308. PubMed ID: 4147382
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological study of piroheptine, a new antiparkinson drug. II. Anticholinergic, antihistaminic, and psychopharmacological actions and toxicity.
    Hitomi M; Watanabe N; Kumadaki N; Kumada S
    Arzneimittelforschung; 1972 Jun; 22(6):961-6. PubMed ID: 4403219
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of oxprenolol (Trasicor, Ciba 39089-Ba) on patterns of urinary sodium excretion in man.
    Singh BN; Till MR; Kelly DT
    Am J Cardiol; 1971 Apr; 27(4):372-5. PubMed ID: 4396725
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dependence between chemical structure and physiological effect in series of aminoketols].
    Loktionov SI; Glukhova RI
    Farmakol Toksikol; 1969; 32(6):662-5. PubMed ID: 4315038
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.